Autolus Therapeutics (AUTL) Total Debt (2017 - 2023)

Autolus Therapeutics posted quarterly Total Debt of $295000.0 for Q3 2023, up 180.95% year-on-year from $105000.0 in Q3 2022, and up 141.8% on a QoQ basis from $122000.0 in Q2 2023.

Autolus Therapeutics (AUTL) has 6 years of Total Debt data on file, last reported at $295000.0 in Q3 2023.

  • For the quarter ending Q3 2023, Total Debt rose 180.95% year-over-year to $295000.0; the trailing twelve-month figure through Sep 2023 stood at $295000.0 (up 180.95% YoY), and the FY2022 full-year result was $116000.0, down 9.38% from the prior year.
  • Total Debt for Q3 2023 stood at $295000.0, up from $122000.0 in the prior quarter.
  • Across five years, Total Debt topped out at $295000.0 in Q3 2023 and bottomed at $30000.0 in Q3 2019.
  • The 4-year median for Total Debt is $118500.0 (2019), against an average of $127000.0.
  • The widest annual swing landed in 2019, when Total Debt sank 92.11%; it then jumped 180.95% in 2023.
  • A 4-year view of Total Debt shows it stood at $30000.0 in 2019, then jumped by 326.67% to $128000.0 in 2021, then dropped by 9.38% to $116000.0 in 2022, then soared by 154.31% to $295000.0 in 2023.
  • The last three Total Debt figures came in at $295000.0 (Q3 2023), $122000.0 (Q2 2023), and $114000.0 (Q1 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 319.10 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 110.96 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 1.99 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn -
10 Autolus Therapeutics - - -1.04 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2023 295,000.00
Jun 30, 2023 122,000.00
Mar 31, 2023 114,000.00
Dec 31, 2022 116,000.00
Sep 30, 2022 105,000.00
Jun 30, 2022 115,000.00
Mar 31, 2022 124,000.00
Dec 31, 2021 128,000.00
Sep 30, 2019 30,000.00
Jun 30, 2019 121,000.00
Dec 31, 2018 285,000.00
Sep 30, 2018 380,000.00
Sep 30, 2017 763,000.00